DBVT Stock Analysis: Buy, Sell, or Hold?
DBVT - DBV Technologies S.A.
$16.17
0.46 (2.96%)
▲
5d:
-10.79%
30d:
-12.95%
90d:
-19.94%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When DBVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DBVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DBVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DBVT is currently trading at $16.16, which is considered oversold relative to its 30-day fair value range of $16.35 to $18.76.
Technical Outlook: Technically, DBVT is in a strong downtrend. Immediate support is located at $15.40, while resistance sits at $18.50.
Market Sentiment: DBVT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.09 (+155.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DBVT is in a strong downtrend. Immediate support is located at $15.40, while resistance sits at $18.50.
Market Sentiment: DBVT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.09 (+155.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.35 -
$18.76
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 155.3% below Wall St target ($40.09)
- CAUTION: 5-day price weakness (-10.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$16.35 -
$18.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.40
Resistance Level
$18.50
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-37.12
Wall Street Target
$40.09
(+155.3%)
Revenue Growth (YoY)
12.5%
Share & Embed Analysis
Last updated: June 23, 2026 3:23 PM ET
Data refreshes hourly during market hours. Next update: 4:23 PM
Data refreshes hourly during market hours. Next update: 4:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Pharis Mohideen
SELL
534 shares
2026-01-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |